Scott T. Rottinghaus insider trades

Open-market stock purchases and sales by Scott T. Rottinghaus, Chief Medical Officer at Enanta Pharmaceuticals Inc, from SEC Form 4 filings since Aug 8, 2022.

Recent trades

DateStockTradeValue
Feb 12, 2026ENTA Enanta Pharmaceuticals IncBought (not open market)—
Feb 12, 2026ENTA Enanta Pharmaceuticals IncBought (not open market)—
Feb 12, 2026ENTA Enanta Pharmaceuticals IncSold (not open market)$48.6K
Dec 5, 2025ENTA Enanta Pharmaceuticals IncSold$11.4K
Nov 25, 2025ENTA Enanta Pharmaceuticals IncBought (not open market)—

Companies traded

  • ENTA Enanta Pharmaceuticals Inc: 6 sales, last Feb 12, 2026

Get free alerts when Scott T. Rottinghaus files a new trade →